 |
|
Multiple Myeloma Trial Results
1. Thalidomide Effective in Multiple Myeloma 3
(Posted: 03/15/2006, Updated: 09/16/2008) - In the March 9, 2006, issue of the New England Journal of Medicine, researchers report superior event-free and complete response rates when the drug thalidomide was used before and during primary therapy for multiple myeloma. Longer follow-up showed a survival benefit for some patients, as well.
2. Bortezomib Approved for First-Line Treatment of Multiple Myeloma 4
(Posted: 09/11/2008) - The targeted drug bortezomib, when added to standard therapy (melphalan and prednisone), significantly improves time to progression and overall survival in patients with newly diagnosed multiple myeloma, according to the August 28, 2008, New England journal of Medicine.
3. Thalidomide a Beneficial Option for Elderly Multiple Myeloma Patients 5
(Posted: 02/12/2008) - Patients aged 75 and over with newly diagnosed multiple myeloma who received the drug thalidomide in addition to standard therapy (melphalan and prednisone) survived longer than patients who received standard therapy plus a placebo, according to clinical trial results presented at the 2007 annual meeting of the American Society of Hematology.
4. Drug Combination Shows Benefit in Relapsed/Refractory Multiple Myeloma 6
(Posted: 08/28/2007) - A new combination treatment should be another standard of care for patients with relapsed or refractory multiple myeloma, according to the Sept. 1, 2007, Journal of Clinical Oncology.
5. Low-dose Steroid Combined with Lenalidomide Prolongs Survival Compared with High-dose Steroid for Multiple Myeloma Treatment 7
(Posted: 04/04/2007) - Preliminary results from a large, randomized clinical trial for patients with newly diagnosed multiple myeloma, a cancer typically found in bone marrow, has shown that use of a low dose of the steroid dexamethasone (Decadron ®), in combination with lenalidomide (Revlimid ®) is associated with improved survival when compared to a treatment regimen with lenalidomide and a higher, standard dose of dexamethasone.
1 2 8 3 9 4 10 Next > 8
|
Table of Links
| 1 | http://www.cancer.gov/cancertopics/types/myeloma |
| 2 | http://www.cancer.gov/clinicaltrials/search |
| 3 | http://www.cancer.gov/clinicaltrials/results/thalidomide-and-myeloma0306 |
| 4 | http://www.cancer.gov/clinicaltrials/results/bortezomib0908 |
| 5 | http://www.cancer.gov/clinicaltrials/results/thalidomide0208 |
| 6 | http://www.cancer.gov/clinicaltrials/results/myeloma0807 |
| 7 | http://www.cancer.gov/newscenter/pressreleases/MultipleMyelomaDexamethasone |
| 8 | http://www.cancer.gov/clinicaltrials/results/multiple-myeloma?keyword=any+myelo
ma&page=2 |
| 9 | http://www.cancer.gov/clinicaltrials/results/multiple-myeloma?keyword=any+myelo
ma&page=3 |
| 10 | http://www.cancer.gov/clinicaltrials/results/multiple-myeloma?keyword=any+myelo
ma&page=4 |
|
|
